Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: A retrospective analysis

被引：0
|
作者：
Papadoniou, N. [1 ]
Kosmas, C. [2 ]
Gennatas, K. [3 ]
Polyzos, A. [4 ]
Mouratidou, D. [5 ]
Skopelitis, E. [6 ]
Sarantonis, I [7 ]
Tzivras, M. [8 ]
Sougioultzis, S. [8 ]
Papastratis, G. [9 ]
Karatzas, G. [10 ]
Diamantis, N. [7 ]
Tsaousi, S. [7 ]
Papalambros, E. [1 ]
Tsavaris, N. [7 ]
机构：
[1] Univ Athens, Sch Med, Laikon Gen Hosp, Dept Surg 1, GR-10679 Athens, Greece
[2] Metaxa Canc Hosp, Dept Med Oncol 2, Piraeus, Greece
[3] Univ Athens, Sch Med, Arete Hosp, Dept Surg 2,Oncol Unit, GR-10679 Athens, Greece
[4] Univ Athens, Sch Med, Laikon Gen Hosp, Propedeut Clin,Dept Internal Med 1,Oncol Unit, GR-10679 Athens, Greece
[5] Theagen Canc Hosp, Dept Med Oncol 2, Thessaloniki, Greece
[6] Gen Hosp Nikea, Med Dpt 2, Piraeus, Greece
[7] Univ Athens, Sch Med, Laikon Gen Hosp, Dept Pathophysiol,Oncol Unit, GR-10679 Athens, Greece
[8] Univ Athens, Sch Med, Laikon Gen Hosp, Dept Pathophysiol,Gastroenterol Unit, GR-10679 Athens, Greece
[9] G Gennimatas Gen Hosp, Dept Surg 3, Athens, Greece
[10] Univ Athens, Sch Med, Attiko Hosp, Dept Surg 3, GR-11527 Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [41] Real-world clinical outcome of unresectable locally advanced & de-novo metastatic pancreatic ductal adenocarcinoma: a multicentre retrospective study
    Aseafan, Mohamed
    Alfakeeh, Ali H.
    Tashkandi, Emad
    Mahrous, Mervat
    Alghamdi, Mohammed
    Alshamsan, Bader
    Al-Hajeili, Marwan
    Bakhsh, Safwan
    Alshammari, Kanan
    Almugbel, Fahad A.
    Alfagih, Abdulhameed H.
    Allehebi, Ahmed
    Montaser, Mohamed
    Elsafty, Mohamed Hamdy
    Elnaghi, Khaled Abd Elaziz
    Issa, Ibrahim
    Bakshi, Eesa
    Alsubaie, Sadeem
    Almutairi, Bandar
    Mokhtar, Hoda
    Aboelatta, Mohamed
    Bukhari, Nedal
    Alzahrani, Ali M.
    Elhassan, Tusneem
    Alqahtani, Ali
    Bazarbashi, Shouki
    BMC CANCER, 2025, 25 (01)
  • [42] Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study
    Inal, A.
    Isikdogan, A.
    Kos, T.
    Algin, E.
    Gumus, M.
    Dikilitas, M.
    Elkiran, E. T.
    Helvaci, K.
    Geredeli, C.
    Dane, F.
    Balakan, O.
    Durnali, A. Gok
    Harputluoglu, H.
    Goksel, G.
    Ozdemir, N.
    Buyukberber, S.
    Yildiz, R.
    Kaplan, M. A.
    Ozkan, M.
    Uncu, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy
    Ueno, H
    Okada, S
    Okusaka, T
    Ikeda, M
    ONCOLOGY, 2000, 59 (04) : 296 - 301
  • [44] Effect of chemoradiation-related lymphopenia on survival in patients with unresectable, locally advanced pancreatic adenocarcinoma
    Wild, Aaron Tyler
    Balmanoukian, Ani Sarkis
    Laheru, Dan
    Zheng, Lei
    Tran, Phuoc T.
    Hacker-Prietz, Amy
    Yovino, Susannah G.
    Kumar, Rachit
    Ziegler, Mark A.
    Pawlik, Timothy M.
    Wolfgang, Christopher Lee
    Grossman, Stuart A.
    Herman, Joseph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [45] Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy
    Trestini, Ilaria
    Carbognin, Luisa
    Sperduti, Isabella
    Bonaiuto, Clelia
    Auriemma, Alessandra
    Melisi, Davide
    Salvatore, Lisa
    Bria, Emilio
    Tortora, Giampaolo
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2018, 72 (05) : 772 - 779
  • [46] CURATIVE INTENT SURGERY IN BORDERLINE RESECTABLE AND LOCALLY ADVANCED UNRESECTABLE PANCREATIC ADENOCARCINOMA: A SEER ANALYSIS
    Corral, Juan E.
    Mousa, Omar
    Kandel, Pujan
    Stauffer, John
    Asbun, Horacio J.
    Raimondo, Massimo
    Kabir, Kabir
    Bi, Yan
    Wallace, Michael B.
    GASTROENTEROLOGY, 2017, 152 (05) : S494 - S495
  • [47] Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy
    Ilaria Trestini
    Luisa Carbognin
    Isabella Sperduti
    Clelia Bonaiuto
    Alessandra Auriemma
    Davide Melisi
    Lisa Salvatore
    Emilio Bria
    Giampaolo Tortora
    European Journal of Clinical Nutrition, 2018, 72 : 772 - 779
  • [48] Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma
    McIntyre, Caitlin A.
    Cohen, Noah A.
    Goldman, Debra A.
    Gonen, Mithat
    Sadot, Eran
    O'Reilly, Eileen M.
    Varghese, Anna M.
    Yu, Kenneth H.
    Balachandran, Vinod P.
    Soares, Kevin C.
    D'Angelica, Michael, I
    Drebin, Jeffrey A.
    Kingham, T. P.
    Allen, Peter J.
    Wei, Alice C.
    Jarnagin, William R.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (03) : 425 - 436
  • [49] Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy
    Ikeda, W
    Okada, S
    Tokuuye, K
    Ueno, H
    Okusaka, T
    CANCER, 2001, 91 (03) : 490 - 495
  • [50] Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy
    Seung-seob Kim
    Sunyoung Lee
    Hee Seung Lee
    Seungmin Bang
    Mi-Suk Park
    Abdominal Radiology, 2021, 46 : 655 - 666
12345